Research, cases and webinars in tricuspid interventions

Brought to you by the PCR Tricuspid Focus Group

The mission of the PCR Tricuspid Focus Group is to facilitate innovation and the development of up-to-date standards of care for patients with tricuspid valve disease, by aligning knowledge, unifying practice and eliminating cultural barriers among physicians and associations worldwide. In this section you will find content created by the Focus Group members, including the Group's digital team: webinars, journal club reviews, news article and cases.

Tricuspid Focus Group
Filtered By
TOPICS

51 results

A patient with multivalvular disease: which approach?

05 Apr 2022

An 81-year-old lady with past history of surgical aortic valve replacement followed by implantation of dual-chamber permanent pacemaker was admitted for recurrent episodes of right heart decompensations. The echocardiographic evaluation revealed massive TR and moderate primary MR due to a retracted posterior leaflet. What would be...

Fabien Praz

Author

Fabien Praz
Alessandro Sticchi

Author

Alessandro Sticchi
A patient with multivalvular disease: which approach?

Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair

10 Feb 2022

The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.

Christopher Allen

Reviewer

Christopher Allen

Reviewer

Alison Duncan
Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair

Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair

27 Jan 2022

As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.

Jonathan Curio

Reviewer

Jonathan Curio
Dr. Gilbert Tang

Reviewer

Gilbert Tang
Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair

Top 10 most cited 2021 articles in the Transcatheter Tricuspid field

11 Jan 2022

A. Sticchi and J. Curio provide you with a summary of the studies that highlighted 2021 in the field of transcatheter tricuspid intervention: TRILUMINATE, CLASP TR EFS, EVOQUE TTVR, TRI-REPAIR, and more.

A. Sticchi and J. Curio

The role of imaging in transcatheter treatment for tricuspid valve disease

Alex Sticchi, interventional cardiologist, interviews Rebecca Hahn, Interventional Echocardiographer, about a recent State of the Art article about transcatheter treatment for tricuspid valve disease published in EuroIntervention.

They discuss the importance of starting with the classification of anatomy and that of secondary TR and identifying how clinical...

An interview with Alex Sticchi and Rebecca Hahn

State-of-the-art: Transcatheter treatment for tricuspid valve disease

19 Nov 2021

 

The development and successful results of transcatheter aortic valve implantation, followed by transcatheter therapies for mitral valve disease have opened a myriad of opportunities for transcatheter treatment of TR. Read this State-of-the-Art paper published in EuroIntervention by the PCR Tricuspid Focus Group.

Transcatheter treatment for tricuspid valve disease

TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review

09 Nov 2021

 

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
TRISCEND Study: six-month outcomes of transfemoral tricuspid valve replacement in patients with tricuspid regurgitation

TRISCEND Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation

07 Nov 2021

Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.

S. Kodali

Author

Susheel Kodali
Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation

#2 - Tricuspid valve interventions: patient and device selection

19 Oct 2021

Discover the replay of this PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig. Learn about transcatheter tricuspid valve procedures, and more!

Tricuspid valve interventions: patient and device selection

#1 - Natural history and prognosis of tricuspid valve disease

23 Sep 2021

PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

Natural history and prognosis of tricuspid valve disease

#3 - Tricuspid valve lifetime management

04 Aug 2021

Watch the replay of this PCR Webinar on tricuspid valve management with L. Sondergaard, H. Treede, N. Wunderlich, L. Conradi, J. Hausleiter and A. Latib

Tricuspid valve lifetime management